DaVita Inc. (NYSE:DVA) Shares Purchased by Integrated Wealth Concepts LLC

Integrated Wealth Concepts LLC grew its position in DaVita Inc. (NYSE:DVA - Free Report) by 81.5% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 9,915 shares of the company's stock after buying an additional 4,452 shares during the period. Integrated Wealth Concepts LLC's holdings in DaVita were worth $1,625,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of DVA. Investment Management Corp of Ontario purchased a new stake in shares of DaVita during the third quarter valued at $279,000. Janus Henderson Group PLC lifted its holdings in DaVita by 8.5% in the third quarter. Janus Henderson Group PLC now owns 5,847 shares of the company's stock valued at $958,000 after acquiring an additional 457 shares during the period. HighTower Advisors LLC boosted its holdings in DaVita by 11.3% during the third quarter. HighTower Advisors LLC now owns 23,335 shares of the company's stock worth $3,813,000 after buying an additional 2,376 shares in the last quarter. Centiva Capital LP boosted its stake in shares of DaVita by 61.2% during the 3rd quarter. Centiva Capital LP now owns 15,207 shares of the company's stock worth $2,493,000 after acquiring an additional 5,776 shares in the last quarter. Finally, Cinctive Capital Management LP acquired a new stake in DaVita in the 3rd quarter valued at $10,093,000. Hedge funds and other institutional investors own 90.12% of the company's stock.

DaVita Trading Down 0.7 %

Shares of DVA stock traded down $1.12 on Friday, hitting $160.25. The stock had a trading volume of 506,762 shares, compared to its average volume of 744,634. The company's 50 day moving average price is $158.58 and its 200-day moving average price is $150.34. DaVita Inc. has a 1 year low of $103.40 and a 1 year high of $169.51. The company has a debt-to-equity ratio of 15.78, a current ratio of 1.37 and a quick ratio of 1.33. The firm has a market capitalization of $13.14 billion, a P/E ratio of 17.29, a P/E/G ratio of 0.92 and a beta of 0.90.

DaVita (NYSE:DVA - Get Free Report) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.76 by ($0.17). DaVita had a net margin of 6.53% and a return on equity of 88.18%. The company had revenue of $3.26 billion during the quarter, compared to analyst estimates of $3.25 billion. During the same period in the prior year, the business earned $2.85 EPS. DaVita's revenue for the quarter was up 4.6% on a year-over-year basis. Analysts anticipate that DaVita Inc. will post 9.71 earnings per share for the current year.

Insider Transactions at DaVita

In other news, CEO Javier Rodriguez sold 9,881 shares of the business's stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $162.85, for a total value of $1,609,120.85. Following the completion of the sale, the chief executive officer now directly owns 887,835 shares of the company's stock, valued at approximately $144,583,929.75. The trade was a 1.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 2.00% of the company's stock.

Wall Street Analyst Weigh In

DVA has been the subject of several research analyst reports. Truist Financial upped their price target on shares of DaVita from $165.00 to $175.00 and gave the stock a "hold" rating in a research report on Monday, October 7th. Barclays lifted their price objective on DaVita from $150.00 to $164.00 and gave the stock an "equal weight" rating in a research report on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $161.80.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.